 | • レポートコード：QFJ1-4908 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、胃がん治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法薬、標的療法薬、生物学的療法、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・胃がん治療薬の市場動向 ・企業の競争状況、市場シェア ・胃がん治療薬の種類別市場規模と予測2016-2027（化学療法薬、標的療法薬、生物学的療法、その他） ・胃がん治療薬の用途別市場規模と予測2016-2027（病院薬局、小売薬局、オンライン薬局） ・胃がん治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・胃がん治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・胃がん治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・胃がん治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・胃がん治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、Eli Lilly、Sanofi、Kuhnil Pharm、Merck & Co、AstraZeneca、Novartis、Taiho Pharmaceutical、Mylan、Celgene Corporation、Boston Biomedical、Jiangsu Hengrui Medicine） ・結論 |
Stomach Cancer Drugs are used to treat stomach malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.
Market Analysis and Insights: Global Stomach Cancer Drugs Market
The global Stomach Cancer Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Stomach Cancer Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Stomach Cancer Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Stomach Cancer Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Stomach Cancer Drugs market.
Global Stomach Cancer Drugs Scope and Market Size
Stomach Cancer Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Stomach Cancer Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Chemo Drugs
Targeted Therapy Drugs
Biological Therapies
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Pfizer
Eli Lilly
Sanofi
Kuhnil Pharm
Merck & Co
AstraZeneca
Novartis
Taiho Pharmaceutical
Mylan
Celgene Corporation
Boston Biomedical
Jiangsu Hengrui Medicine
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Stomach Cancer Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemo Drugs
1.2.3 Targeted Therapy Drugs
1.2.4 Biological Therapies
1.2.5 Others
1.3 Market by Application
1.3.1 Global Stomach Cancer Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Stomach Cancer Drugs Market Perspective (2016-2027)
2.2 Stomach Cancer Drugs Growth Trends by Regions
2.2.1 Stomach Cancer Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Stomach Cancer Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Stomach Cancer Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Stomach Cancer Drugs Industry Dynamic
2.3.1 Stomach Cancer Drugs Market Trends
2.3.2 Stomach Cancer Drugs Market Drivers
2.3.3 Stomach Cancer Drugs Market Challenges
2.3.4 Stomach Cancer Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Stomach Cancer Drugs Players by Revenue
3.1.1 Global Top Stomach Cancer Drugs Players by Revenue (2016-2021)
3.1.2 Global Stomach Cancer Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Stomach Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Stomach Cancer Drugs Revenue
3.4 Global Stomach Cancer Drugs Market Concentration Ratio
3.4.1 Global Stomach Cancer Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Stomach Cancer Drugs Revenue in 2020
3.5 Stomach Cancer Drugs Key Players Head office and Area Served
3.6 Key Players Stomach Cancer Drugs Product Solution and Service
3.7 Date of Enter into Stomach Cancer Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Stomach Cancer Drugs Breakdown Data by Type
4.1 Global Stomach Cancer Drugs Historic Market Size by Type (2016-2021)
4.2 Global Stomach Cancer Drugs Forecasted Market Size by Type (2022-2027)
5 Stomach Cancer Drugs Breakdown Data by Application
5.1 Global Stomach Cancer Drugs Historic Market Size by Application (2016-2021)
5.2 Global Stomach Cancer Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Stomach Cancer Drugs Market Size (2016-2027)
6.2 North America Stomach Cancer Drugs Market Size by Type
6.2.1 North America Stomach Cancer Drugs Market Size by Type (2016-2021)
6.2.2 North America Stomach Cancer Drugs Market Size by Type (2022-2027)
6.2.3 North America Stomach Cancer Drugs Market Size by Type (2016-2027)
6.3 North America Stomach Cancer Drugs Market Size by Application
6.3.1 North America Stomach Cancer Drugs Market Size by Application (2016-2021)
6.3.2 North America Stomach Cancer Drugs Market Size by Application (2022-2027)
6.3.3 North America Stomach Cancer Drugs Market Size by Application (2016-2027)
6.4 North America Stomach Cancer Drugs Market Size by Country
6.4.1 North America Stomach Cancer Drugs Market Size by Country (2016-2021)
6.4.2 North America Stomach Cancer Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Stomach Cancer Drugs Market Size (2016-2027)
7.2 Europe Stomach Cancer Drugs Market Size by Type
7.2.1 Europe Stomach Cancer Drugs Market Size by Type (2016-2021)
7.2.2 Europe Stomach Cancer Drugs Market Size by Type (2022-2027)
7.2.3 Europe Stomach Cancer Drugs Market Size by Type (2016-2027)
7.3 Europe Stomach Cancer Drugs Market Size by Application
7.3.1 Europe Stomach Cancer Drugs Market Size by Application (2016-2021)
7.3.2 Europe Stomach Cancer Drugs Market Size by Application (2022-2027)
7.3.3 Europe Stomach Cancer Drugs Market Size by Application (2016-2027)
7.4 Europe Stomach Cancer Drugs Market Size by Country
7.4.1 Europe Stomach Cancer Drugs Market Size by Country (2016-2021)
7.4.2 Europe Stomach Cancer Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Stomach Cancer Drugs Market Size (2016-2027)
8.2 Asia-Pacific Stomach Cancer Drugs Market Size by Type
8.2.1 Asia-Pacific Stomach Cancer Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Stomach Cancer Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Stomach Cancer Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Stomach Cancer Drugs Market Size by Application
8.3.1 Asia-Pacific Stomach Cancer Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Stomach Cancer Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Stomach Cancer Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Stomach Cancer Drugs Market Size by Region
8.4.1 Asia-Pacific Stomach Cancer Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Stomach Cancer Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Stomach Cancer Drugs Market Size (2016-2027)
9.2 Latin America Stomach Cancer Drugs Market Size by Type
9.2.1 Latin America Stomach Cancer Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Stomach Cancer Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Stomach Cancer Drugs Market Size by Type (2016-2027)
9.3 Latin America Stomach Cancer Drugs Market Size by Application
9.3.1 Latin America Stomach Cancer Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Stomach Cancer Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Stomach Cancer Drugs Market Size by Application (2016-2027)
9.4 Latin America Stomach Cancer Drugs Market Size by Country
9.4.1 Latin America Stomach Cancer Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Stomach Cancer Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Stomach Cancer Drugs Market Size (2016-2027)
10.2 Middle East & Africa Stomach Cancer Drugs Market Size by Type
10.2.1 Middle East & Africa Stomach Cancer Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Stomach Cancer Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Stomach Cancer Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Stomach Cancer Drugs Market Size by Application
10.3.1 Middle East & Africa Stomach Cancer Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Stomach Cancer Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Stomach Cancer Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Stomach Cancer Drugs Market Size by Country
10.4.1 Middle East & Africa Stomach Cancer Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Stomach Cancer Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Stomach Cancer Drugs Introduction
11.1.4 Pfizer Revenue in Stomach Cancer Drugs Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Eli Lilly
11.2.1 Eli Lilly Company Details
11.2.2 Eli Lilly Business Overview
11.2.3 Eli Lilly Stomach Cancer Drugs Introduction
11.2.4 Eli Lilly Revenue in Stomach Cancer Drugs Business (2016-2021)
11.2.5 Eli Lilly Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Stomach Cancer Drugs Introduction
11.3.4 Sanofi Revenue in Stomach Cancer Drugs Business (2016-2021)
11.3.5 Sanofi Recent Development
11.4 Kuhnil Pharm
11.4.1 Kuhnil Pharm Company Details
11.4.2 Kuhnil Pharm Business Overview
11.4.3 Kuhnil Pharm Stomach Cancer Drugs Introduction
11.4.4 Kuhnil Pharm Revenue in Stomach Cancer Drugs Business (2016-2021)
11.4.5 Kuhnil Pharm Recent Development
11.5 Merck & Co
11.5.1 Merck & Co Company Details
11.5.2 Merck & Co Business Overview
11.5.3 Merck & Co Stomach Cancer Drugs Introduction
11.5.4 Merck & Co Revenue in Stomach Cancer Drugs Business (2016-2021)
11.5.5 Merck & Co Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Stomach Cancer Drugs Introduction
11.6.4 AstraZeneca Revenue in Stomach Cancer Drugs Business (2016-2021)
11.6.5 AstraZeneca Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Stomach Cancer Drugs Introduction
11.7.4 Novartis Revenue in Stomach Cancer Drugs Business (2016-2021)
11.7.5 Novartis Recent Development
11.8 Taiho Pharmaceutical
11.8.1 Taiho Pharmaceutical Company Details
11.8.2 Taiho Pharmaceutical Business Overview
11.8.3 Taiho Pharmaceutical Stomach Cancer Drugs Introduction
11.8.4 Taiho Pharmaceutical Revenue in Stomach Cancer Drugs Business (2016-2021)
11.8.5 Taiho Pharmaceutical Recent Development
11.9 Mylan
11.9.1 Mylan Company Details
11.9.2 Mylan Business Overview
11.9.3 Mylan Stomach Cancer Drugs Introduction
11.9.4 Mylan Revenue in Stomach Cancer Drugs Business (2016-2021)
11.9.5 Mylan Recent Development
11.10 Celgene Corporation
11.10.1 Celgene Corporation Company Details
11.10.2 Celgene Corporation Business Overview
11.10.3 Celgene Corporation Stomach Cancer Drugs Introduction
11.10.4 Celgene Corporation Revenue in Stomach Cancer Drugs Business (2016-2021)
11.10.5 Celgene Corporation Recent Development
11.11 Boston Biomedical
11.11.1 Boston Biomedical Company Details
11.11.2 Boston Biomedical Business Overview
11.11.3 Boston Biomedical Stomach Cancer Drugs Introduction
11.11.4 Boston Biomedical Revenue in Stomach Cancer Drugs Business (2016-2021)
11.11.5 Boston Biomedical Recent Development
11.12 Jiangsu Hengrui Medicine
11.12.1 Jiangsu Hengrui Medicine Company Details
11.12.2 Jiangsu Hengrui Medicine Business Overview
11.12.3 Jiangsu Hengrui Medicine Stomach Cancer Drugs Introduction
11.12.4 Jiangsu Hengrui Medicine Revenue in Stomach Cancer Drugs Business (2016-2021)
11.12.5 Jiangsu Hengrui Medicine Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Stomach Cancer Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemo Drugs
Table 3. Key Players of Targeted Therapy Drugs
Table 4. Key Players of Biological Therapies
Table 5. Key Players of Others
Table 6. Global Stomach Cancer Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Stomach Cancer Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Stomach Cancer Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Stomach Cancer Drugs Market Share by Regions (2016-2021)
Table 10. Global Stomach Cancer Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Stomach Cancer Drugs Market Share by Regions (2022-2027)
Table 12. Stomach Cancer Drugs Market Trends
Table 13. Stomach Cancer Drugs Market Drivers
Table 14. Stomach Cancer Drugs Market Challenges
Table 15. Stomach Cancer Drugs Market Restraints
Table 16. Global Stomach Cancer Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Stomach Cancer Drugs Market Share by Players (2016-2021)
Table 18. Global Top Stomach Cancer Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Stomach Cancer Drugs as of 2020)
Table 19. Ranking of Global Top Stomach Cancer Drugs Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Stomach Cancer Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Stomach Cancer Drugs Product Solution and Service
Table 23. Date of Enter into Stomach Cancer Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Stomach Cancer Drugs Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Stomach Cancer Drugs Revenue Market Share by Type (2016-2021)
Table 27. Global Stomach Cancer Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Stomach Cancer Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Stomach Cancer Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Stomach Cancer Drugs Revenue Market Share by Application (2016-2021)
Table 31. Global Stomach Cancer Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Stomach Cancer Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Stomach Cancer Drugs Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Stomach Cancer Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Stomach Cancer Drugs Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Stomach Cancer Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Stomach Cancer Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Stomach Cancer Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Stomach Cancer Drugs Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Stomach Cancer Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Stomach Cancer Drugs Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Stomach Cancer Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Stomach Cancer Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Stomach Cancer Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Stomach Cancer Drugs Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Stomach Cancer Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Stomach Cancer Drugs Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Stomach Cancer Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Stomach Cancer Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Stomach Cancer Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Stomach Cancer Drugs Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Stomach Cancer Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Stomach Cancer Drugs Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Stomach Cancer Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Stomach Cancer Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Stomach Cancer Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Stomach Cancer Drugs Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Stomach Cancer Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Stomach Cancer Drugs Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Stomach Cancer Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Stomach Cancer Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Stomach Cancer Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 63. Pfizer Company Details
Table 64. Pfizer Business Overview
Table 65. Pfizer Stomach Cancer Drugs Product
Table 66. Pfizer Revenue in Stomach Cancer Drugs Business (2016-2021) & (US$ Million)
Table 67. Pfizer Recent Development
Table 68. Eli Lilly Company Details
Table 69. Eli Lilly Business Overview
Table 70. Eli Lilly Stomach Cancer Drugs Product
Table 71. Eli Lilly Revenue in Stomach Cancer Drugs Business (2016-2021) & (US$ Million)
Table 72. Eli Lilly Recent Development
Table 73. Sanofi Company Details
Table 74. Sanofi Business Overview
Table 75. Sanofi Stomach Cancer Drugs Product
Table 76. Sanofi Revenue in Stomach Cancer Drugs Business (2016-2021) & (US$ Million)
Table 77. Sanofi Recent Development
Table 78. Kuhnil Pharm Company Details
Table 79. Kuhnil Pharm Business Overview
Table 80. Kuhnil Pharm Stomach Cancer Drugs Product
Table 81. Kuhnil Pharm Revenue in Stomach Cancer Drugs Business (2016-2021) & (US$ Million)
Table 82. Kuhnil Pharm Recent Development
Table 83. Merck & Co Company Details
Table 84. Merck & Co Business Overview
Table 85. Merck & Co Stomach Cancer Drugs Product
Table 86. Merck & Co Revenue in Stomach Cancer Drugs Business (2016-2021) & (US$ Million)
Table 87. Merck & Co Recent Development
Table 88. AstraZeneca Company Details
Table 89. AstraZeneca Business Overview
Table 90. AstraZeneca Stomach Cancer Drugs Product
Table 91. AstraZeneca Revenue in Stomach Cancer Drugs Business (2016-2021) & (US$ Million)
Table 92. AstraZeneca Recent Development
Table 93. Novartis Company Details
Table 94. Novartis Business Overview
Table 95. Novartis Stomach Cancer Drugs Product
Table 96. Novartis Revenue in Stomach Cancer Drugs Business (2016-2021) & (US$ Million)
Table 97. Novartis Recent Development
Table 98. Taiho Pharmaceutical Company Details
Table 99. Taiho Pharmaceutical Business Overview
Table 100. Taiho Pharmaceutical Revenue in Stomach Cancer Drugs Business (2016-2021) & (US$ Million)
Table 101. Taiho Pharmaceutical Recent Development
Table 102. Mylan Company Details
Table 103. Mylan Business Overview
Table 104. Mylan Stomach Cancer Drugs Product
Table 105. Mylan Revenue in Stomach Cancer Drugs Business (2016-2021) & (US$ Million)
Table 106. Mylan Recent Development
Table 107. Celgene Corporation Company Details
Table 108. Celgene Corporation Business Overview
Table 109. Celgene Corporation Stomach Cancer Drugs Product
Table 110. Celgene Corporation Revenue in Stomach Cancer Drugs Business (2016-2021) & (US$ Million)
Table 111. Celgene Corporation Recent Development
Table 112. Boston Biomedical Company Details
Table 113. Boston Biomedical Business Overview
Table 114. Boston Biomedical Stomach Cancer Drugs Product
Table 115. Boston Biomedical Revenue in Stomach Cancer Drugs Business (2016-2021) & (US$ Million)
Table 116. Boston Biomedical Recent Development
Table 117. Jiangsu Hengrui Medicine Company Details
Table 118. Jiangsu Hengrui Medicine Business Overview
Table 119. Jiangsu Hengrui Medicine Stomach Cancer Drugs Product
Table 120. Jiangsu Hengrui Medicine Revenue in Stomach Cancer Drugs Business (2016-2021) & (US$ Million)
Table 121. Jiangsu Hengrui Medicine Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Stomach Cancer Drugs Market Share by Type: 2020 VS 2027
Figure 2. Chemo Drugs Features
Figure 3. Targeted Therapy Drugs Features
Figure 4. Biological Therapies Features
Figure 5. Others Features
Figure 6. Global Stomach Cancer Drugs Market Share by Application: 2020 VS 2027
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Stomach Cancer Drugs Report Years Considered
Figure 11. Global Stomach Cancer Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Stomach Cancer Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Stomach Cancer Drugs Market Share by Regions: 2020 VS 2027
Figure 14. Global Stomach Cancer Drugs Market Share by Regions (2022-2027)
Figure 15. Global Stomach Cancer Drugs Market Share by Players in 2020
Figure 16. Global Top Stomach Cancer Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Stomach Cancer Drugs as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Stomach Cancer Drugs Revenue in 2020
Figure 18. Global Stomach Cancer Drugs Revenue Market Share by Type (2016-2021)
Figure 19. Global Stomach Cancer Drugs Revenue Market Share by Type (2022-2027)
Figure 20. North America Stomach Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Stomach Cancer Drugs Market Share by Type (2016-2027)
Figure 22. North America Stomach Cancer Drugs Market Share by Application (2016-2027)
Figure 23. North America Stomach Cancer Drugs Market Share by Country (2016-2027)
Figure 24. United States Stomach Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Stomach Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Stomach Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Stomach Cancer Drugs Market Share by Type (2016-2027)
Figure 28. Europe Stomach Cancer Drugs Market Share by Application (2016-2027)
Figure 29. Europe Stomach Cancer Drugs Market Share by Country (2016-2027)
Figure 30. Germany Stomach Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Stomach Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Stomach Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Stomach Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Stomach Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Stomach Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Stomach Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Stomach Cancer Drugs Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Stomach Cancer Drugs Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Stomach Cancer Drugs Market Share by Region (2016-2027)
Figure 40. China Stomach Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Stomach Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Stomach Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Stomach Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Stomach Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Stomach Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Stomach Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Stomach Cancer Drugs Market Share by Type (2016-2027)
Figure 48. Latin America Stomach Cancer Drugs Market Share by Application (2016-2027)
Figure 49. Latin America Stomach Cancer Drugs Market Share by Country (2016-2027)
Figure 50. Mexico Stomach Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Stomach Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Stomach Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Stomach Cancer Drugs Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Stomach Cancer Drugs Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Stomach Cancer Drugs Market Share by Country (2016-2027)
Figure 56. Turkey Stomach Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Stomach Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Stomach Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Pfizer Revenue Growth Rate in Stomach Cancer Drugs Business (2016-2021)
Figure 60. Eli Lilly Revenue Growth Rate in Stomach Cancer Drugs Business (2016-2021)
Figure 61. Sanofi Revenue Growth Rate in Stomach Cancer Drugs Business (2016-2021)
Figure 62. Kuhnil Pharm Revenue Growth Rate in Stomach Cancer Drugs Business (2016-2021)
Figure 63. Merck & Co Revenue Growth Rate in Stomach Cancer Drugs Business (2016-2021)
Figure 64. AstraZeneca Revenue Growth Rate in Stomach Cancer Drugs Business (2016-2021)
Figure 65. Novartis Revenue Growth Rate in Stomach Cancer Drugs Business (2016-2021)
Figure 66. Taiho Pharmaceutical Revenue Growth Rate in Stomach Cancer Drugs Business (2016-2021)
Figure 67. Mylan Revenue Growth Rate in Stomach Cancer Drugs Business (2016-2021)
Figure 68. Celgene Corporation Revenue Growth Rate in Stomach Cancer Drugs Business (2016-2021)
Figure 69. Boston Biomedical Revenue Growth Rate in Stomach Cancer Drugs Business (2016-2021)
Figure 70. Jiangsu Hengrui Medicine Revenue Growth Rate in Stomach Cancer Drugs Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
世界の非小細胞肺がん治療薬市場規模・現状・予測（2021年-2027年） Non-small-cell lung carcinoma (NSCLC) is any type of epithelial lung cancer other than small cell lung carcinoma (SCLC). NSCLC accounts for about 85% of all lung cancers. The strong drug pipeline and drug approvals are one of the critical factors that will trigger the non-small cell lung cancer drug…- 世界のがん支持療法薬剤市場規模・現状・予測（2021年-2027年） Supportive drugs are not anticancer drugs. They protect certain cells or organs from the side effects of chemotherapy drugs or radiation therapy. Increasing uptake of biosimilars, rising expenditure on healthcare, and availability of effective treatment methods, including target specific and tailore…
- 世界のβ-ラクタム系薬剤市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Beta-Lactam Drugs Market The global Beta-Lactam Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a…
- 世界の体部白癬治療薬市場規模・現状・予測（2021年-2027年） Tinea corporis, also known as ringworm, is a superficial fungal infection (dermatophytosis) of the arms and legs, especially on glabrous skin; however, it may occur on any part of the body. It is similar to other forms of tinea. Market Analysis and Insights: Global Tinea Corporis Drugs Market The gl…
- 世界の心理療法薬市場規模・現状・予測（2021年-2027年） Psychotherapy is a collaborative approach used by psychologists to help people overcome various mental illnesses and emotional difficulties. Market Analysis and Insights: Global Psychotherapeutic Drugs Market The global Psychotherapeutic Drugs market size is projected to reach US$ XX million by 2027…